Log In
|
Join
|
Search
|
Site Map
|
Contact
Home
About AAAS
Programs
Membership
Publications
News
Career Resources
Education
|
Science & Policy
|
International Activities
Advanced search
AAAS Events & Links
Events
AAAS Board
AAAS Council
AAAS Elections
AAAS Statements
AAAS Store
Annual Meeting
Archives
Awards
Development
Education
Employment
Experts
Governance
International
Make a Gift
Media Relations
Membership
Organization
Press Releases
Science
Science Books & Film
Science & Policy
Categories:
>>
Health
Updates
|
Legislation
|
Hearings
|
Publications
|
Meetings
|
Subcategories
Updates
British Scientists "Invent Around" Protections on Patented Drug
Eli Lilly Patent Decision Upheld
Heightened Activity on Greater Open Access to Scientific Research for Disadvantaged Nations
Thailand Pursues Compulsory License for Anti-AIDS Drug
"Philadelphia Consensus Statement" Calls upon WHO, Academia, to Bolster Poor Nations' Benefits from Health Research
U.S. Commerce Secretary: China Must Strengthen Copyright Infringement Laws
WTO Director-General Calls Upon Poor Nations to Enact Compulsory Licensing for Critical Patented Drugs
USPTO to Re-examine Basis for Three Patents on Human Embryonic Stem Cells
New India-based Initiative to Oppose Patenting of HIV Medications
Generic Copy of Anti-clotting Drug Forced Off of Market in U.S.
Generic Drug-maker Challenges Patent
Canada Institutes Humanitarian Endeavor to Make Information and Medicine More Easily Available to Impoverished Countries
Federal Trade Commission Weighs in on Access to Generic Drugs
Pharmaceutical Company Refuses to Market Drug Over Price Disagreement
Korea Reforms Health Insurance Policy, Tightens Funding for Multinational Drug Companies
Late Patent Extension Request Spurs Proposed Legislation in House
US-Morocco FTA Provisions for Intellectual Property Rules Draw Attention from the United Nations
FDA Approves a "Biosimilar" Copy of a Biotechnology-Derived Drug
Brazil Seeks to Apply Traditional Knowledge for Pharmaceutical Purposes, Prevention of Biopiracy
WHO to Study Effects of International Drug Patent System on Low-Income Nations
Gilead Sciences' Plan for Non-exclusive Licensing of AIDS Drug Met with Mixed Reactions
Patent Dispute Arises From Discovery Made Over 20 Years Ago
FTC Reports on Legal Settlements to Generic Drug Manufacturers
April 26: Sixth World Intellectual Property Day Observed With Activities Throughout the World
New Trade Association Analysis: Generic Forms of Widely-used Drugs Face Challenges in the Marketplace
Heavy Volume of Patent Applications Before FDA's Office of Generic Drugs Could Bolster Profits of Name-brand Drug Producers
Patenting of AIDS Drug in India Meets Legal Resistance
Sanofi-Aventis and Bristol-Myers Squibb Reach Settlement on Patent for Well-Known Blood Thinner
Tuesday, March 21: Landmark Patent Case Before Supreme Court
Patent Status as a Factor in Drug Pricing?
Cleveland Clinic Grants Exclusive Rights to Company to Advance Therapy for Damaged Hearts
U.S.-Thai Trade Talks Muddled Over Intellectual Property Rights Provisions
Approval Process for Biotech-derived Generic Drugs Not Yet Established
Amendment to WTO's Intellectual Property Rules Eases Poor Countries' Access to Generic Drugs
WTO Grants Poorest Nations Less Time than Requested to Adhere to International Intellectual Property Rules
Kucinich, 12 House Democrats Object to Proposed Privatization of Open Access Scientific Journal
China Second only to U.S. in Ownership of Health-Based Nanotechnology Patents
BioShield II Legislation Closer to Compromise on Drug Patenting
Representative Brown Introduces Bill to Enact Compulsory Licensing During Healthcare Crises
Senator Schumer Calls for “Immediate Licensing” to Allow U.S. Manufacturers to Produce the Antiviral Drug Tamiflu
European Commission Remains Vague on Biotechnology Patenting; Industry Disappointed
South Centre and CIEL: Quarterly Update on IP and Development
Emory Sells AIDS Drug Rights for Record $525 Million
Brazil and Abbott Reach Deal on Kaletra
Brazil May Break Patent on HIV/AIDS Drug
ETC Reports on Impact of Nanotechnology Patents for Global South
Supreme Court Interprets Broader Exemption for Drug Research
WHO Holds Workshop and Open Forum on IP, Innovation and Health
Brazil’s Lower House Votes to Suspend AIDS Drug Patents
WHO Studies on IP and Health Available Online
Wellcome Trust Announces Six Month Open Access Policy
Debate on Bioshield II Patent Provisions at Center for American Progress
Celera Will Make DNA Information Free
Israeli Scientist's AIDS Discovery Languishes in IP Disputes
Merck v. Integra Briefs Available Online
Senators Propose Patent Extensions to Spur Biodefense R&D
Database of Traditional Tibetan Drugs Goes Online
Amicus Brief on Research Exemption Submitted to Supreme Court
Proposed Medical R&D Treaty Would Provide Alternative Incentives for Innovation
OECD Issues Draft Guidelines for Licensing Genetic Inventions
NIH Asks Grantees to Voluntarily Release Published Articles
Brazil Reshapes Debate on Intellectual Property
US Pressures Guatemala to Revise Data Protection Law
Supreme Court Will Hear Merck v. Integra
NIH Open Access Publishing Policy Release Postponed
World Bank Releases Two Books on IP and Development
April 2005: WIPO Meeting on Establishing a Development Agenda
Germany Passes New Biotech Patent Law
New Open Access Initiative from Publishers and Advocacy Groups
WHO Initiates 23 Studies on IPRs, Innovation and Public Health
GSK Tells Blair to Press G8 for Patent Reform
Guatemala Repeals Data Exclusivity Rule
Epogen Patent Ruling: UK Will Not Allow Overly Broad Claims
European Commission Proposes Generic Export Regulation
NAS Committee on IPRs in Genetic and Protein-Related Inventions: Meeting Transcript and Presentations Available
“Innovation Sails Free”: Newsweek Article on Open Source Science
Greenpeace Challenges Stem Cell Patent
UK Court Revokes Amgen Patent
Drug Maker Promotes Generics for Workers
Venture Capitalists Support CA Stem Cell Initiative
Judge Rules for Amgen Patents
Digene Settles Patent Dispute over HPV Test
Genomics and Public Health: New Report on Science for the MDGs
Patents in Pharmaceutical R&D: Discussion in Bulletin of the WHO
Open Source Biotech Starts in Earnest
Samoa to Profit from Indigenous Knowledge Deal
Funding Pharmaceutical R&D: Alternatives to the Patent System
Biomedical R&D Funders Requiring Collaboration
GSK Licenses AIDS Drugs in Kenya
Zambia Issues Compulsory License for AIDS Drug
Expiring Patents Drive Drug Companies to Merge
Pubpat Challenges Pfizer's Lipitor Patent
China Considering Compulsory Licenses for AIDS Drugs
Chiron Settles HIV Test Patent Dispute With Roche
Medical Journals Require Drug Trials to be Made Public
NIH Requests Comments on Open Access Policy
Rep. Istook to Discuss Open Access on House Floor
ALRC Recommends Gene Patenting Changes for Australia
NIH Proceeds With Plan to Provide Open Access to Scientific Papers
AIDS Drugs: Is Patent the Obstacle?
Vermont Sues FDA Over Drug Reimportation
Congressman Brown Asks Thompson to Reverse NIH Norvir Decision
Traditional Medicines Must Be Registered and Studied
Federal Stem Cell Lines Declared "Suitable" for Research
Britain allows cloning of human cells for research
FDA Warns of Terrorist Drug Tampering
NIH Decides Not to Intervene on Norvir Pricing
Merck Licenses AIDS Drug to South African Generic Manufacturer
Poor Countries Can Import Generics Without E.U. Rule
Chinese Challenge Diabetes Drug Patent
NIH Director Meets with Publishers on Open Access
Open Access Language Appears in NIH Appropriations Report
AIDS Healthcare Foundation Drops Norvir Lawsuits
Language Barrier Slows Access to Generic Drugs
Text of U.S. Representatives' Letter on FTAs
WHO Solicits Comments on IP and Health Plan
Free Access to NIH-Funded Research Recommended by House Appropriations Committee
AHF and Abbott settle
Congress Approves Project BioShield
Government to Open "Stem Cell Bank"
China Overturns Viagra Patent
Drug Companies Try to Improve Public Image
Pfizer Expands Discount Drug Progam
World Health Organization Proposes Global Drug Trial Registry
Texas Medical Association Backs Stem Cell Research
Generic 3-in-1 AIDS Pill Effective in Study
Mylan Sues FDA Over Generic Pain-Relief Patch
Draft text of US-Bahrain Free Trade Agreement
Kerry Supports Further Stem Cell Research
Open-Source Drug Discovery Proposed for Neglected Diseases
Fifty-Eight Senators Urge Pres. Bush to Expand Stem Cell Policy
Sen. Gregg Introduces FDA-Approved Bill for Drug Importation
Aetna Drops Antitrust Suit Against Abbott
Central American Free Trade Agreement (CAFTA) and U.S.-Bahrain FTA
Both Sides Speak Out at Norvir March-In Meeting
Thailand To Give Free AIDS Drugs To Other Countries
Speakers for NIH May 25 Norvir March-in meeting
Sens Hollings, McCain, and Schumer ask FTC to inquire into Norvir price increase
Breast Cancer Gene Patent Revoked in Europe
PLoS Launches Open Access Medical Journal
HHS Attempting to Ensure Rapid Delivery of ARV's
Patent Office Grants PUBPAT Request To Reexamine Cotransformation Patent
Six House Republicans Ask for Hearings on Norvir Pricing
AAAS Supports Policy Push for Broader Access to New Human Embryonic Stem Cell Lines
HHS Sec. Declares Drug Importation "Helpful, Inevitable"
New Case Against Abbott Laboratories
China Announces Free AIDS Drugs and Testing
Federal Hearing on Importing Cheaper Drugs
Federal hearing on importing cheaper drugs
Appeals Ruling Could Impact Combination Drug Development
WTO to host public symposium on the Doha Agenda
New Deal reached by Coalition to provide AIDS drugs to poor
Patent threat to anti-HIV compounds is lifted
WHO launches intellectual property commission
Legislation
Pharmaceutical Market Access and Drug Safety Act of 2004
Stem Cell Research Enhancement Act of 2004
Reliable Entry for Medicines at Everyday Discounts through Importation with Effective Safeguards Act of 2004 (REMEDIES Act)
Greater Access to Affordable Pharmaceuticals Act
Greater Access to Affordable Pharmaceuticals Act (S 1225)
Hearings
Publications
A Fair Deal for the Future: Flexibilities Under TRIPS
Financing Drug Research: What are the Issues?
Genes and Ingenuity: Gene Patenting and Human Health
Has the Implementation of the TRIPS Agreement in Latin America and the Caribbean Produced Intellectual Property Legislation that Favours Public Health?
Integrating Intellectual Property Rights and Development
Open Access and the Public Domain in Digital Data and Information for Science: Proceedings of an International Symposium
Ownership of knowledge - the role of patents in pharmaceutical R&D
SPARC Letter to NIH on Open Access
Scientific Publications: Free for All?
Traditional Knowledge and Intellectual Property
Meetings
17 Jan 2007 10:00: Hearing: Paying off Generics to Prevent Competition with Brand Name Drugs
26 Jun 2006 9:00: Secretary's Advisory Committee on Genetics, Health, and Society: 10th Meeting
27 May 2005 8:30: Gene Patents and Public Health
21 Apr 2005 13:30: Bridging the Divide 2005 : Technology, Innovation and Learning in Developing Economies
25 Oct 2004 8:30: Global Challenges for Guiding and Managing Biological Technologies - meeting of the NAS Board on Agriculture and Natural Resources
20 Oct 2004 12:00: Gene Patenting and Human Health - Lunchtime Talk
4 Oct 2004: BIO IP Counsel Committee Meeting
18 Sep 2004: Patent Policy: Using, Abusing and Reforming
5 Aug 2004 8:00: National Academies: IP in Genomic and Protein Research and Innovation
4 Jun 2004: Public Workshop: Intellectual Property Rights in Genomic and Protein-Related Inventions
25 May 2004 9:00: NIH Norvir March-in Meeting
25 May 2004: Multilateralism at a Crossroads: WTO annual public symposium
5 May 2004 10:00: Fifth listening session on drug importation
Copyright © 2009. American Association for the Advancement of Science.
All rights reserved.
Read our
privacy policy
and
terms of use
.
Contact info.
Science & Human Rights
About
Projects & Activities
Science & IP News
Home
Meetings
Legislation
Publications
Cases
Organizations
Hearings